Homology Medicines Inc. (FIXX)
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 8:00 PM
0.26% (1D)
| Bid | n/a |
| Market Cap | 3.02M |
| Revenue (ttm) | 1.77M |
| Net Income (ttm) | -83.09M |
| EPS (ttm) | -35.1 |
| PE Ratio (ttm) | -0.026629629629629628 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 401,467 |
| Avg. Volume (20D) | 29,535 |
| Open | 0.92 |
| Previous Close | 0.93 |
| Day's Range | 0.90 - 0.97 |
| 52-Week Range | 0.90 - 26.64 |
| Beta | -0.11 |
About FIXX
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company ...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 28, 2018
Employees 7
Stock Exchange NASDAQ
Ticker Symbol FIXX